66 related articles for article (PubMed ID: 30659028)
1. Role of HPV genotyping in risk assessment among cytology diagnosis categories: analysis of 4562 cases with cytology-HPV cotesting and follow-up biopsies.
Ge Y; Christensen P; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR
Int J Gynecol Cancer; 2019 Feb; 29(2):234-241. PubMed ID: 30659028
[TBL] [Abstract][Full Text] [Related]
2. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
3. Aptima Human Papillomavirus E6/E7 mRNA Test Results Strongly Associated With Risk for High-Grade Cervical Lesions in Follow-Up Biopsies.
Ge Y; Christensen P; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR
J Low Genit Tract Dis; 2018 Jul; 22(3):195-200. PubMed ID: 29543688
[TBL] [Abstract][Full Text] [Related]
4. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
Ding Z; Li Y; Chen A; Song M; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
Castle PE; Eaton B; Reid J; Getman D; Dockter J
J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
[TBL] [Abstract][Full Text] [Related]
6. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
7. Does high-risk human papilloma virus genotyping of abnormal anal cytology improve detection of high-grade anal intraepithelial neoplasia?
Walts AE; Manna P; Chan RC; Kerley S; Bose S
J Am Soc Cytopathol; 2014; 3(5):236-243. PubMed ID: 31051676
[TBL] [Abstract][Full Text] [Related]
8. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
10. Potential hazards of following atypical and low-grade cervical cytology without colposcopy.
Nyirjesy I; Billingsley FS
Prim Care Update Ob Gyns; 1998 Jul; 5(4):162. PubMed ID: 10838302
[TBL] [Abstract][Full Text] [Related]
11. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
[TBL] [Abstract][Full Text] [Related]
13. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.
Wright TC; Stoler MH; Parvu V; Yanson K; Cooper C; Andrews J
Gynecol Oncol; 2019 Aug; 154(2):360-367. PubMed ID: 31160073
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus.
Cheng SH; Wang CC; Chang SL; Chu FY; Hsueh YM
Int J Clin Oncol; 2015 Oct; 20(5):943-51. PubMed ID: 25712159
[TBL] [Abstract][Full Text] [Related]
16. Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: A retrospective study of 1414 cases.
Sun Y; Wang T; Zhong F; Starr D; Zeng X; Zhang H; Xiao J; Zhou X; Tao X; Zhao C
Cancer Cytopathol; 2024 Jun; ():. PubMed ID: 38879864
[TBL] [Abstract][Full Text] [Related]
17. The utility of high-risk HPV testing in the management of women 30 to 64 years of age with low-grade squamous intraepithelial lesions on cervical cytology.
Selvaggi SM
J Am Soc Cytopathol; 2015; 4(5):290-293. PubMed ID: 31051767
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
19. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
Yang L; Zhu Y; Bai Y; Zhang X; Ren C
J Cancer Res Ther; 2017; 13(4):613-620. PubMed ID: 28901302
[TBL] [Abstract][Full Text] [Related]
20. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
